Accolade (ACCD) Stock Price
Accolade Price
Over the last 6 years Accolade grew revenue by 33.2% annually, reaching 408.34 M USD. For Accolade, the net margin of -24.4% is up versus -39.6% a few years ago. The consensus 12-month price target for Accolade is 7.17 USD, about 2.1% above where the stock trades today. Of 18 analysts, 7 rate the stock a buy — an overall Hold consensus.
Accolade stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Accolade over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Accolade stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Accolade's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Accolade Price |
|---|
Accolade Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Accolade Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 0.09 | 0.13 | 0.17 | 0.31 | 0.36 | 0.41 | 0.47 | 0.53 | 0.64 | 0.81 | 0.91 | 1.02 |
| – | 23.68 | 40.43 | 28.79 | 82.35 | 17.10 | 14.05 | 12.80 | 12.63 | 22.24 | 25.19 | 13.04 | 12.20 |
| 30.26 | 36.17 | 43.94 | 44.71 | 45.48 | 45.18 | 46.38 | 46.38 | 46.38 | 46.38 | 46.38 | 46.38 | 46.38 |
| 23.00 | 34.00 | 58.00 | 76.00 | 141.00 | 164.00 | 192.00 | 216.58 | 243.94 | 298.20 | 373.33 | 422.03 | 473.51 |
| -59.00 | -54.00 | -48.00 | -46.00 | -171.00 | 135.00 | -114.00 | – | -101.00 | -53.00 | 23.00 | 37.00 | – |
| -77.63 | -57.45 | -36.36 | -27.06 | -55.16 | 37.19 | -27.54 | – | -19.20 | -8.24 | 2.86 | 4.07 | – |
| -61.00 | -56.00 | -51.00 | -50.00 | -123.00 | -459.00 | -99.00 | -21.00 | -16.00 | 8.00 | – | – | – |
| – | -8.20 | -8.93 | -1.96 | 146.00 | 273.17 | -78.43 | -78.79 | -23.81 | -150.00 | – | – | – |
| 4.83 | 5.78 | 51.58 | 71.49 | 71.23 | 76.14 | 80.65 | 80.65 | 80.65 | 80.65 | 80.65 | 80.65 | 80.65 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Accolade generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Accolade retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Accolade's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Accolade has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Accolade's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Accolade stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Accolade Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Accolade business model & stock analysis
Accolade SWOT Analysis
Strengths
Accolade Inc. has several strengths that contribute to its success in the market. These include:
- Strong brand reputation: Accolade Inc. is widely recognized and respected in the industry.
- Diverse product portfolio: The company offers a wide range of products, catering to different customer needs.
- Innovative technology: Accolade Inc. continually invests in research and development, resulting in cutting-edge products and solutions.
- Strong financial position: The company has a solid financial foundation, allowing it to withstand market fluctuations and invest strategically.
- Strong customer base: Accolade Inc. has established long-term relationships with a large and loyal customer base.
Weaknesses
Despite its strengths, Accolade Inc. also faces certain weaknesses that may hinder its growth and success:
- Dependence on key customers: The loss of a major customer could significantly impact the company's financial performance.
- Limited international presence: Accolade Inc. primarily operates in domestic markets, which may restrict its growth opportunities.
- Reliance on third-party suppliers: The company relies on external suppliers for certain key components, making it susceptible to supply chain disruptions.
- High competition: The industry in which Accolade Inc. operates is highly competitive, requiring continuous innovation and differentiation.
- Dependence on specific market segments: Accolade Inc.'s success depends on specific market segments, making it vulnerable to changes in consumer preferences.
Opportunities
Accolade Inc. can leverage various opportunities to enhance its market position and drive growth:
- Expansion into new markets: Exploring untapped domestic and international markets can help diversify the company's revenue streams.
- Technological advancements: The increasing demand for technologically advanced products presents opportunities for Accolade Inc. to develop innovative solutions.
- Increase in healthcare spending: Rising healthcare expenditures create a favorable environment for Accolade Inc. to offer premium products and services.
- Partnerships and collaborations: Collaborating with other industry leaders or forming strategic alliances can expand Accolade Inc.'s market reach and capabilities.
- Changing regulatory landscape: Adapting to evolving regulations and compliance requirements can create opportunities for Accolade Inc. to gain a competitive edge.
Threats
Accolade Inc. faces several threats that pose risks to its business and market position:
- Intense market competition: The industry is characterized by fierce competition, with numerous players vying for market share.
- Economic downturns: Economic instability and recessions can impact consumer spending, potentially leading to a decline in demand for Accolade Inc.'s products.
- Rapid technological advancements: Failure to keep pace with technological changes may render Accolade Inc.'s products obsolete or less desirable in the market.
- Changing healthcare policies: Shifts in healthcare policies and regulations may affect reimbursement rates or market access for Accolade Inc.'s products.
- Supply chain disruptions: Disruptions in the supply chain, such as natural disasters or geopolitical issues, can disrupt production and compromise product availability.
Accolade Segments
Accolade Revenue by Segment
Max
Details
Accolade Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Accolade historical P/E ratio, EBIT multiple, and P/S ratio
Accolade annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Accolade shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Accolade forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 0.00 % |
| Buy | 38.89 % (7) |
| Hold | 61.11 % (11) |
| Sell | 0.00 % (0) |
| 12M Price Target | 7.17 |
| Last Price | 7.02 |
| Currency | USD |
| 12M Return Potential | 2.15 % |
| LTM Return | 0 % |
Accolade Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 1/7/2026 | -0.27USD | 123.58 MUSD | 2026 Q3 |
| 6/27/2024 | -0.40USD | 112.87 MUSD | 2025 Q1 |
| 4/25/2024 | -0.14USD | 128.86 MUSD | 2024 Q4 |
| 1/8/2024 | -0.52USD | 102.81 MUSD | 2024 Q3 |
| 10/4/2023 | -0.55USD | 95.88 MUSD | 2024 Q2 |
| 6/28/2023 | -0.60USD | 95.84 MUSD | 2024 Q1 |
| 4/26/2023 | -0.42USD | 103.19 MUSD | 2023 Q4 |
| 1/9/2023 | -0.63USD | 88.86 MUSD | 2023 Q3 |
| 10/6/2022 | -0.74USD | 84.11 MUSD | 2023 Q2 |
| 6/30/2022 | -0.68USD | 83.20 MUSD | 2023 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Accolade stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Accolade shareholder structure
| % | Name |
|---|---|
0.26458% | |
0.23913% | |
0.07570% | |
0.01874% | |
0.01314% | |
0.01287% |
Accolade Executives and Management Board
Ms. Snezana Mahon
President
Mr. Glen Tullman
Chief Executive Officer
Ms. Stephanie Peng
Chief Financial Officer
Mr. Kristen Bruzek
Executive Vice President, Chief Service Delivery Officer
Mr. Praful Kaul
Chief Technology Officer
Accolade Supply Chain
Accolade Supply Chain
Correlation: how closely stock prices move together
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | 0.48 | -0.10 | 0.18 | 0.78 | — | ||
| 2 | 0.47 | 0.71 | 0.89 | -0.30 | — | ||
| 3 | 0.39 | -0.48 | -0.66 | 0 | — | ||
| 4 | 0.16 | -0.46 | 0.58 | -0.04 | — | ||
| 5 | 0.18 | 0.42 | 0.65 | 0.59 | — |
Frequently asked questions about Accolade
Accolade Inc operates as a healthcare technology and services company. The company's business model is based on providing personalized health and benefits solutions to individuals and their families. Accolade's services include healthcare navigation, behavioral health support, benefits advisory, and chronic condition management. By combining technology and human touch, Accolade aims to simplify and improve access to healthcare for its clients. Through their platform, Accolade Inc aims to empower individuals in making informed healthcare decisions, managing their health conditions, and optimizing their overall well-being. Accolade Inc strives to enhance healthcare outcomes and reduce costs for both individuals and employers.
Accolade stock
Accolade Peer Group
Accolade Ticker
Accolade FIGI
All fundamentals and in-depth analysis of Accolade
Our stock analysis for Accolade stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accolade. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.